CN101257949A - 清凉化合物 - Google Patents

清凉化合物 Download PDF

Info

Publication number
CN101257949A
CN101257949A CNA200680029790XA CN200680029790A CN101257949A CN 101257949 A CN101257949 A CN 101257949A CN A200680029790X A CNA200680029790X A CN A200680029790XA CN 200680029790 A CN200680029790 A CN 200680029790A CN 101257949 A CN101257949 A CN 101257949A
Authority
CN
China
Prior art keywords
isopropyl
chemical compound
branched alkyl
independently selected
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA200680029790XA
Other languages
English (en)
Other versions
CN101257949B (zh
Inventor
K·A·拜尔
C·加洛宾
J·P·斯莱克
L·迪加尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan SA
Original Assignee
Givaudan SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan SA filed Critical Givaudan SA
Publication of CN101257949A publication Critical patent/CN101257949A/zh
Application granted granted Critical
Publication of CN101257949B publication Critical patent/CN101257949B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • A23L2/56Flavouring or bittering agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/24Thermal properties
    • A61K2800/244Endothermic; Cooling; Cooling sensation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)

Abstract

一种向产品提供清凉效果的方法,包括将至少一种式I化合物结合至产品中,其中,m为0-2的数,X、Y和Z独立地选自H、卤素、OH、Me、Et、MeO和EtO,R1、R2和R3一起包含至少6个碳,其以如下方式进行选择:(a)(i)R1选自H、Me、Et、异丙基和C4-C5支链烷基;和(ii)R2和R3独立地选自Me、Et、异丙基和C4-支链烷基;或(b)R1、R2和R3中的任意两个或全部一起形成具有最多10个碳的单环、二环或三环基团。所述化合物向施用于皮肤或口服摄入的组合物,例如牙膏、漱口液、食品、饮料、糖果、烟草制品、皮肤乳霜和软膏赋予实质性的清凉效果。

Description

清凉化合物
本发明涉及清凉化合物。
清凉化合物,即赋予皮肤或身体黏膜清凉感觉的化学化合物,已经为本领域所公知,而且广泛用于各种产品,例如食物、烟草制品、饮料、洁齿剂、漱口剂和化妆用品中。
一类相当成功的清凉化合物为N-取代的对-薄荷烷甲酰胺。这些化合物的例子在例如英国专利GB 1,351,761、GB 1,351,762和美国专利US 4,150,052中进行了描述。
现在发现,特别选择的这种化合物显示令人惊讶地强烈和长效的清凉作用。因此,提供一种向产品提供清凉作用的方法,其包括将至少一种式I化合物结合至产品中,
Figure A20068002979000051
其中,m为0-2的数,X、Y和Z独立地选自H、卤素、OH、Me、Et、MeO和EtO,R1、R2和R3一起包含至少6个碳,其以如下方式进行选择:
(a)(i)R1选自H、Me、Et、异丙基和C4-C5支链烷基;和
(ii)R2和R3独立地选自Me、Et、异丙基和C4-支链烷基;或
(b)R1、R2和R3中的任意两个或全部一起形成具有最多10个碳的单环、二环或三环基团。
Me定义为甲基,Et定义为乙基。
上述(b)中定义的环状基团的例子包括3-对-薄荷基、冰片基和金刚烷基。
式(I)化合物可以包括一个或多个手性中心,这样其就可能作为立体异构体混合物而存在,或者可以被拆分为异构纯的形式。异构体的拆分为这些化合物的制备和纯化增加了复杂性,因此仅仅出于经济原因优选使用作为立体异构体混合物形式的化合物。但是,如果希望制备单独的立体异构体,则可以根据本领域已知的方法,例如制备性HPLC和GC或通过立体选择性合成法来实现该目的。
在一些实施方案中,所述化合物为其中X、Y、Z为H、OH、Me或OMe的化合物。在某些实施方案中,所述化合物为其中m为2,X、Y和Z为H或Me,且R1、R2和R3按照表1进行选取而形成的化合物。
表1:示例性R1、R2和R3基团
Figure A20068002979000061
特别有效的化合物是其中R1为H,且R2和R3一起形成3-对-薄荷基环的化合物。
有效的化合物的例子为(1R,2S,5R)-2-异丙基-5-甲基-N-(吡啶烷基)环己烷甲酰胺和(2S,5R)-2-异丙基-5-甲基-N-(吡啶烷基)环己烷甲酰胺。这些化合物的特殊例子为(1R,2S,5R)-2-异丙基-5-甲基-N-(2-(吡啶-4-基)乙基)环己烷甲酰胺和(2S,5R)-2-异丙基-5-甲基-N-(2-(吡啶-4-基)乙基)环己烷甲酰胺。
某些所述化合物是新的。因此提供如上所述的式I化合物,其中m=2,X、Y、Z、R1、R2、R3具有上述含义,条件是当R2和R3形成对-薄荷基环时,R1、X、Y和Z中的至少一个不为H。
还提供根据上述式I的下述化合物,其中X、Y、Z、R1为H,R2,R3具有上述含义。
在某些实施方案中,R1为氢,R2和R3独立地选自Me、Et和C3-C4支链烷基;或者R1、R2和R3一起形成最多具有10个碳的单环、二环或三环基团。
通过本领域已知的方法可以容易地制备和分离所述化合物。
它们与现有技术中类似化合物的区别在于其出人意料的高清凉效果(最多可以比类似的已知化合物高100倍)和该清凉效果的长效性。这些化合物在油性溶剂例如薄荷油,和酸性水溶液例如软饮料中还具有高溶解性。这些特征扩展了清凉化合物在更多产品中的用途。
所述化合物可以在施用于口腔或皮肤的产品中使用,以便得到清凉感。“施用”是指任何形式的接触,例如口服摄取,或者对于烟草制品而言是指吸入。当施用于皮肤时,可以例如在乳霜或软膏或者在可喷式组合物中包含该化合物。因此,本发明还提供一种给口腔或皮肤提供清凉作用的方法,包括向其施用含有上述化合物的产品。
可以使用所述化合物的产品的范围非常大,仅作为例子而言包括洁齿剂例如牙膏和牙凝胶、漱口液、食品、饮料、糖果、烟草制品、皮肤乳霜和软膏,既包括化妆品也包括医药制品。
所述化合物可以单独使用也可以与本领域已知的其他清凉化合物结合使用,所述其他清凉化合物例如为
薄荷醇、薄荷酮、异胡薄荷醇、N-乙基对-薄荷烷甲酰胺(WS-3)、N,2,3-三甲基-2-异丙基丁酰胺(WS-23)、乳酸薄荷酯(FrescolatTM ML)、薄荷酮甘油乙缩醛(FrescolatTM MGA)、琥珀酸单薄荷酯(PhyscoolTM)、戊二酸单薄荷酯、甘油单薄荷酯(CoolActTM 10)、薄荷基-N,N-二甲基琥珀酰胺酸酯和2-仲丁基环己酮(FreskomentheTM)。
现在借助下列非限制性实施例对某些实施方案做进一步描述。
实施例1
N-(4-吡啶基)对-薄荷烷甲酰胺[(1R,2S,5R)-2-异丙基-5-甲基-N-(2-(吡啶-4-基)乙基)环己烷甲酰胺]的制备
向烧瓶中加入4.7g(50mmol)吡啶-4-基胺、4.04mL吡啶和100mLMtBE。经5分钟向该混合物中滴加10g对-薄荷烷甲酰氯。搅拌反应混合物24小时。向反应混合物中加入50mL水。分离混合物。有机层用50mL水和50mL盐水洗涤。在MgSO4上干燥有机层。真空蒸发溶剂得到粗产物,其从己烷中重结晶而得到6.2g希望的产品,其具有下列光谱性质:
MS:260([M]),217,149,121,95
1H NMR(300MHz;CDCl3)δ:8.49(d,2H),7.77(s,1H),7.52(d,2H),2.22(td,1H),1.9(宽d,2H),1.85-1.57(m,3H),1.44-1.22(m,2H),1.16-0.99(m,2H),0.94(d,3H),0.91(d,3H),0.81(d,3H)
13C NMR(75MHz;CDCl3)δ:175.4,150.5,145.0,113.4,50.7,44.3,39.25,34.3,32.1,28.7,23.7,22.1,21.2,16.1
实施例2
N-(2-吡啶-2-基乙基)对-薄荷烷甲酰胺[(1R,2S,5R)-2-异丙基-5-甲基-N-(2-(吡啶-2-基)乙基)环己烷甲酰胺]的制备:
按照与实施例1中所述的类似的方法制备得到希望的产品,其具有下列光谱性质:
MS:288([M]),273,245,149,121,95
1H NMR(300MHz;DMSO)δ:8.53(d,1H),7.62(td,1H),7.16(m,2H),6.43(s,1H),3.67(九重峰,2H),3.00(t,2H),1.95(td,1H),1.84-1.53(m,4H),1.47(宽t,1H),1.4-1.1(m,2H),0.87(d,3H),0.84(d,3H),0.66(d,3H)
13C NMR(75MHz;DMSO)δ:175.8,159.7,148.9,136.7,123.6,121.55,49.8,44.3,39.4,38.35,36.9,34.6,32.3,28.55,23.9,22.3,21.3,15.95
实施例3
2-异丙基-2,3-二甲基-N-(2-(吡啶-2-基)乙基)丁酰胺的制备:
按照与实施例1中所述的类似的方法,使用2-异丙基-2,3-二甲基丁酰氯制备得到希望的产品,其具有下列光谱性质:
MS:262([M+]),220,205,149,121,106,93
1H NMR(300MHz;CDCl3)8.53(d,1H),7.63(t,1H),7.16(m,2H),6.69(s,1H),3.67(dd,2H),2.99(t,2H),1.96(m,2H),0.96(s,3H),0.85(d,6H),0.79(d,6H)
13C(75MHz;CDCl3)175.6,160.0,149.1,136.6,123.4,121.5,51.4,38.4,36.9,32.6,18.1,17.4,14.1
实施例4
对清凉效果的评价
让一小组鉴定组人员品尝清凉化合物的各种水溶液,并指出哪个溶液与2ppm的薄荷醇溶液具有类似或稍高的清凉强度。让同一鉴定组品尝选定浓度下的这些溶液并在规律的时间间隔下记录清凉强度,直至口中不再有清凉感觉为止。结果示于表2中。
表2:清凉强度和持续性试验
化合物   浓度   持续时间
l-薄荷醇   2.0ppm   35分钟
N-乙基对-薄荷烷甲酰胺(WS-3)   1.5ppm   57分钟
式I,m=0,X=Y=Z=R1=H,R2+R3=对薄荷基(实施例1化合物)   0.5ppm   50分钟
式I,m=2,X=Y=Z=R1=H,R2+R3=对薄荷基(实施例2化合物)   0.02ppm   60分钟
式I,m=2,X=Y=Z=H,R1=甲基,R2=R3=异丙基(实施例3化合物) 0.4ppm
从表2中可以看出,式I化合物比参考性清凉化合物薄荷醇的强度和持续时间高出最多100倍。式I化合物还比现有技术中最好的清凉化合物WS-3强烈许多。
在第二个试验中,让同一鉴定组品尝具有不同浓度的各种化合物溶液,并指出哪个溶液与2ppm的薄荷醇溶液具有类似或稍高的清凉强度。这就是“等强浓度”。结果示于表3中。
表3:当R2+R3=对-薄荷烷,R1=X=Y=Z=H时化合物的强度
  m值(链长)   主要部分所在的环位置   等强浓度
  0   2或6   0.2ppm
  0   3或5   0.4ppm
  0   4   0.5ppm
  1   2或6   0.67ppm
  1   3或5   0.25ppm
  1   4   0.2ppm
  2   2或6   0.02ppm
  2   3或5   0.004ppm
  2**   4**   0.05ppm
实施例1的化合物
**实施例2的化合物
从表2和3中可以看出,具有不同链长和取代形式的式I化合物都比参考性清凉化合物薄荷醇和WS-3具有更低的使用水平。
实施例5
在漱口液中的应用
乙醇95%                               177mL
山梨糖醇70%                           250g
实施例1的化合物,其为乙醇中的1%溶液   50mL
无萜薄荷油                             0.300g
水杨酸甲酯                             0.640g
桉油精                                 0.922g
百里酚                                 0.639g
苯甲酸                                 1.500g
PluronicTM F127非离子表面活性剂        5.000g
糖精钠                                 0.600g
柠檬酸钠                               0.300g
柠檬酸                                 0.100g
水                                     适量至1升
混合所有成分。将30mL所得溶液放入口中、来回搅动、漱口并吐出。口腔的每一区域和嘴唇都感觉到冰凉感。
实施例6
在牙膏中的应用
不透明牙凝胶                                97.000g
实施例2的化合物,其为在丙二醇中的2%溶液    2.500g
无萜薄荷油                                  0.500g
将化合物混合在牙凝胶中,将一条牙凝胶放于牙刷上并且给鉴定组人员用于刷牙。用水漱口并且将水吐出。鉴定组人员口腔中的每一区域都感觉到强烈的清凉感。
实施例7
在饮料中的应用
将1.5mg实施例2的化合物溶解在355mL(12 fl oz.)的澄清柠檬/酸橙苏打罐中。鉴定组人员在口腔中体验到一定时间令人愉悦的清凉感,无喉咙灼烧感。未体察到不愉快的余味。
虽然通过上面的详细描述和前面的实施例对本发明进行了描述,但是这些实施例仅仅用于说明目的,应该理解在不偏离本发明的精神和范围的情况下本领域熟练技术人员可以进行变化和变型。应该理解上述实施方案不仅可以相互替换而且可以结合起来。

Claims (6)

1、一种向产品提供清凉效果的方法,包括将至少一种式I化合物结合至产品中,
其中,m为0-2的数,X、Y和Z独立地选自H、卤素、OH、Me、Et、MeO和EtO,R1、R2和R3一起包含至少6个碳,其以如下方式进行选择:
(a)(i)R1选自H、Me、Et、异丙基和C4-C5支链烷基;和
(ii)R2和R3独立地选自Me、Et、异丙基和C4-支链烷基;或
(b)R1、R2和R3中的任意两个或全部一起形成具有最多10个碳的单环、二环或三环基团。
2、根据权利要求1的方法,其中在该化合物中X、Y、Z独立地选自H、OH、Me和OMe。
3、根据权利要求1的方法,其中m为2;X、Y和Z独立地选自H和Me,R1、R2和R3根据下表进行选择:
Figure A20068002979000022
4、根据权利要求1的方法,其中R1为H,R2和R3一起形成3-对-薄荷基环。
5、一种适于施用于皮肤或口服摄入的产品,其包括至少一种根据式I的化合物:
Figure A20068002979000031
其中,m为0-2的数,X、Y和Z独立地选自H、卤素、OH、Me、Et、MeO和EtO,R1、R2和R3一起包含至少6个碳,其以如下方式进行选择:
(a)(i)R1选自H、Me、Et、异丙基和C4-C5支链烷基;和
(ii)R2和R3独立地选自Me、Et、异丙基和C4-支链烷基;或
(b)R1、R2和R3中的任意两个或全部一起形成具有最多10个碳的单环、二环或三环基团。
6、式I化合物:
Figure A20068002979000032
其中,m=2,X、Y和Z独立地选自H、卤素、OH、Me、Et、MeO和EtO,R1、R2和R3一起包含至少6个碳,其以如下方式进行选择:
(a)(i)R1选自H、Me、Et、异丙基和C4-C5支链烷基;和
(ii)R2和R3独立地选自Me、Et、异丙基和C4-支链烷基;或
(b)R1、R2和R3中的任意两个或全部一起形成具有最多10个碳的单环、二环或三环基团;
条件是当R2和R3形成对-薄荷烷环时,R1、X、Y和Z中的至少一个不为H。
CN200680029790XA 2005-08-15 2006-08-14 清凉化合物 Active CN101257949B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70815305P 2005-08-15 2005-08-15
US60/708,153 2005-08-15
PCT/CH2006/000427 WO2007019719A1 (en) 2005-08-15 2006-08-14 Cooling compounds

Publications (2)

Publication Number Publication Date
CN101257949A true CN101257949A (zh) 2008-09-03
CN101257949B CN101257949B (zh) 2011-01-19

Family

ID=37215970

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200680029790XA Active CN101257949B (zh) 2005-08-15 2006-08-14 清凉化合物

Country Status (7)

Country Link
US (3) US9452982B2 (zh)
EP (1) EP1917074B1 (zh)
JP (1) JP5383191B2 (zh)
CN (1) CN101257949B (zh)
BR (1) BRPI0616821B1 (zh)
ES (1) ES2668361T3 (zh)
WO (1) WO2007019719A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106860034A (zh) * 2011-02-23 2017-06-20 奇华顿股份有限公司 有机化合物

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4786544B2 (ja) 2003-11-21 2011-10-05 ジボダン エス エー N置換p−メンタンカルボキサミド類
GB0704163D0 (en) * 2007-03-02 2007-04-11 Quest Int Serv Bv Compositions comprising a physiological coolant
WO2008134908A1 (en) 2007-05-08 2008-11-13 Givaudan Sa Wax encapsulation
WO2008141469A2 (en) * 2007-05-23 2008-11-27 Givaudan Sa Butone derivatives useful as cooling agents
JP2010528631A (ja) 2007-06-06 2010-08-26 ジボダン エス エー 塩味増強
ATE540667T1 (de) 2007-06-13 2012-01-15 Givaudan Sa Verbindungen mit kühlender wirkung
US7880011B2 (en) 2007-07-23 2011-02-01 Givandan, S.A. Amide addition reaction
US8377422B2 (en) * 2007-12-07 2013-02-19 Givaudan S.A. Carboxamide derivatives having cooling properties
WO2009076792A1 (en) 2007-12-19 2009-06-25 Givaudan Sa Cooling compounds
DE102008015428A1 (de) * 2008-03-20 2009-09-24 Beiersdorf Ag Kühlende Zubereitungen für den humanen Haut- und/oder Schleimhautkontakt mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid
DE102008015426A1 (de) 2008-03-20 2009-09-24 Beiersdorf Ag Kühlende kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid zu Reduktion von Hautrötungen
DE102008015425A1 (de) * 2008-03-20 2010-01-21 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen zur Verringerung von Juckreiz und anderen dermatologischen Missempfindungen, die insbesondere bei Altershaut auftreten können, mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid
DE102008015424A1 (de) * 2008-03-20 2009-09-24 Beiersdorf Ag Kühlende kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5- methylcyclohexancarboxamid mit Menthoxypropandiol
JP2011520925A (ja) * 2008-05-22 2011-07-21 ジボダン エス エー 清涼組成物
CA2734682C (en) 2008-08-26 2017-09-26 Basf Se Detection and use of low molecular-weight modulators of the cold-menthol receptor trpm8
CN102271651A (zh) 2008-12-30 2011-12-07 荷兰联合利华有限公司 凝固的洁齿剂组合物
WO2010128026A2 (en) * 2009-05-05 2010-11-11 Givaudan Sa Organic compounds
CN102497787A (zh) * 2009-07-29 2012-06-13 奇华顿股份有限公司 有机化合物中或与之相关的改进
BR112012001599A2 (pt) 2009-07-29 2016-03-08 Unilever Nv composição dentifricia
DE102010002558A1 (de) 2009-11-20 2011-06-01 Symrise Ag Verwendung physiologischer Kühlwirkstoffe und Mittel enthaltend solche Wirkstoffe
EP2394703B1 (de) 2010-06-14 2015-12-23 Symrise AG Kühlmischungen mit verstärkter Kühlwirkung von 5-Methyl-2-(propan-2-yl)cyclohexyl-N-ethyloxamat
US9029415B2 (en) 2010-06-14 2015-05-12 Symrise Ag Cooling mixtures with an enhanced cooling effect of 5-methyl-2-(propane-2-yl)cyclohexyl-N-ethyloxamate
CN108434004A (zh) 2011-07-26 2018-08-24 奇华顿股份有限公司 漂洗组合物
EP2758041B1 (de) 2011-09-20 2021-01-13 Basf Se Niedermolekulare modulatoren des kälte-menthol-rezeptors trpm8 und deren verwendung
BR112018006471B1 (pt) 2015-10-01 2024-02-27 Senomyx, Inc Composto, composição, método de modular o membro de melastina do canal potencial do receptor transitório 8 (trpm8), método de modular a sensação de resfrescância de uma composição e método de induzir uma sensação de refrescância em um ser humano ou animal
EP3509641A1 (en) 2016-09-12 2019-07-17 ST IP Holding AG Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1.2-dithiole-3-thione, taste-modified formulations, and methods of making and using same
JP2019531344A (ja) 2016-09-12 2019-10-31 エスティー アイピー ホールディング エージー 4−メチル−5−(ピラジン−2−イル)−3h−1,2−ジチオール−3−チオンの処方物、ならびにそれらの製造方法及び使用方法
JP2018203645A (ja) * 2017-05-31 2018-12-27 ライオン株式会社 口腔用組成物
CN111343963B (zh) 2017-08-31 2023-09-12 巴斯夫欧洲公司 生理清凉活性成分的用途以及包含此类活性成分的组合物
EP3806661A1 (en) 2018-08-10 2021-04-21 Firmenich Incorporated Antagonists of t2r54 and compositions and uses thereof
JP2020070263A (ja) * 2018-11-01 2020-05-07 ライオン株式会社 液体口腔用組成物
EP3689324A1 (de) 2019-02-04 2020-08-05 Symrise AG Neue kühlstoffe und zubereitungen, die diese enthalten
US11135220B1 (en) 2020-04-08 2021-10-05 St Ip Holding Ag Methods of treating viral infections with formulated compositions comprising 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione
WO2022105986A1 (de) 2020-11-17 2022-05-27 Symrise Ag Neue kühlstoffe und zubereitungen, die diese enthalten
WO2023143741A1 (de) 2022-01-28 2023-08-03 Symrise Ag Neue kühlstoffe und zubereitungen, die diese enthalten
WO2022207944A2 (en) 2022-07-11 2022-10-06 Symrise Ag Novel mixtures and uses of (2e)-3-(1,3-benzodioxol-5-yl)-n-phenyl-n-(tetrahydro-3-furanyl)-2-propenamide

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1179261A (en) * 1915-10-25 1916-04-11 Ralph Wymore Wireless check-row planter.
CH491111A (de) * 1966-01-28 1970-05-31 Geigy Ag J R Verfahren zur Herstellung von neuen Amiden aliphatischer Carbonsäuren
US3516943A (en) * 1966-12-06 1970-06-23 Ncr Co Replacement of capsule contents by diffusion
US4136163A (en) * 1971-02-04 1979-01-23 Wilkinson Sword Limited P-menthane carboxamides having a physiological cooling effect
GB1351761A (en) 1971-02-04 1974-05-01 Wilkinson Sword Ltd Substituted p-menthane carboxamides and compositions containing them
US4190643A (en) * 1971-02-04 1980-02-26 Wilkinson Sword Limited Compositions having a physiological cooling effect
US4150052A (en) * 1971-02-04 1979-04-17 Wilkinson Sword Limited N-substituted paramenthane carboxamides
AU7593174A (en) 1973-12-12 1976-06-03 Wilkinson Sword Ltd Compounds having a physiological cooling effect
US4285984A (en) * 1976-08-09 1981-08-25 Givaudan Corporation Flavoring with dialkylamino-alkylene mercaptans and sulfides
IL83163A (en) * 1986-07-18 1991-06-10 Erba Carlo Spa Cycloalkyl-substituted 4-pyridyl derivatives,their preparation and pharmaceutical compositions containing them
US5009893A (en) * 1989-07-17 1991-04-23 Warner-Lambert Company Breath-freshening edible compositions of methol and a carboxamide
US5759599A (en) * 1992-03-30 1998-06-02 Givaudan Roure Flavors Corporation Method of flavoring and mechanically processing foods with polymer encapsulated flavor oils
JPH07506868A (ja) * 1992-05-18 1995-07-27 ザ、プロクター、エンド、ギャンブル、カンパニー 冷却剤組成物
JPH11502195A (ja) * 1995-03-16 1999-02-23 ザ、プロクター、エンド、ギャンブル、カンパニー 清涼組成物
US5843466A (en) * 1995-08-29 1998-12-01 V. Mane Fils S.A. Coolant compositions
US6056949A (en) * 1995-10-27 2000-05-02 Givaudan Roure (International) Sa Aromatic granulated material
US6306818B1 (en) * 1996-06-24 2001-10-23 Givaudan Roure (International) Sa Fragrance precursors
DE69726446T2 (de) * 1996-10-09 2004-08-26 Givaudan S.A. Verfahren zur herstellung eines perlförmigen nahrungsmittelzusatzes
US6325859B1 (en) * 1996-10-09 2001-12-04 Givaudan Roure (International) Sa Process for preparing beads as food or tobacco additive
US6039901A (en) * 1997-01-31 2000-03-21 Givaudan Roure Flavors Corporation Enzymatically protein encapsulating oil particles by complex coacervation
US6045835A (en) * 1997-10-08 2000-04-04 Givaudan Roure (International) Sa Method of encapsulating flavors and fragrances by controlled water transport into microcapsules
US6106875A (en) 1997-10-08 2000-08-22 Givaudan Roure (International) Sa Method of encapsulating flavors and fragrances by controlled water transport into microcapsules
SG74666A1 (en) * 1997-10-21 2000-08-22 Givaudan Roure Int Beta-ketoester
SG71201A1 (en) * 1998-04-20 2000-03-21 Givaudan Roure Int Hydroxa-methyl-hexanones
ATE367845T1 (de) * 1998-06-15 2007-08-15 Procter & Gamble Riechstoffzusammensetzungen
JP2002520405A (ja) * 1998-07-17 2002-07-09 ジボーダン ルール (アンテルナシヨナル)ソシエテ アノニム ジカルボアルコキシジオキソラン
EP0987018A3 (en) * 1998-08-27 2000-04-26 Givaudan Roure (International) S.A. Post-foaming shower gel
US6108875A (en) * 1999-05-18 2000-08-29 National Molding Corp. Lockable strap divider
ATE254101T1 (de) * 1999-05-28 2003-11-15 Givaudan Sa Mercaptoalkohol-verbindungen als als geschmackstoffe
US6805893B2 (en) * 1999-05-28 2004-10-19 Givaudan Sa Mercapto-alkanol flavor compounds
US6689740B1 (en) * 1999-06-15 2004-02-10 Givaudan Sa Method for preparing fragrance products
ZA200003120B (en) * 1999-06-30 2001-01-02 Givaudan Roure Int Encapsulation of active ingredients.
AU7247000A (en) * 2000-01-11 2001-07-19 Givaudan Sa Composite materials
US6451366B1 (en) * 2000-11-06 2002-09-17 Givaudan Sa Epoxydecenal isomers
US6335047B1 (en) * 2000-11-06 2002-01-01 Givaudan Sa Epoxydecenal isomers
US6348625B1 (en) * 2000-11-10 2002-02-19 Gloria Long Anderson Method for preparing some 1-adamantancecarboxamides
US20050214337A1 (en) * 2002-02-26 2005-09-29 Mcgee Thomas Pesticidal compositions
US20030165587A1 (en) * 2002-02-28 2003-09-04 Givaudan Sa Production of 2-furfurylthiol in brassica seed and use of same
EP1348423A1 (en) * 2002-03-27 2003-10-01 Givaudan SA Fragrance compositions
JP2005533897A (ja) * 2002-07-25 2005-11-10 ジボダン エス エー 香り(Flavourant)化合物
AU2003271498A1 (en) * 2002-10-28 2004-05-13 Givaudan Sa Coolant solutions and compositions comprising the sameitle
US20060035008A1 (en) * 2002-11-14 2006-02-16 Givaudan Sa Edible film containing food acid
GB0301662D0 (en) * 2003-01-24 2003-02-26 Givaudan Sa Improvements in or relating to organic compounds
GB0306152D0 (en) * 2003-03-19 2003-04-23 Givaudan Sa Method
CN102389409B (zh) 2003-07-02 2014-01-22 健泰科生物技术公司 Trp-p8活性化合物和治病性治疗方法
US8362264B2 (en) * 2003-08-22 2013-01-29 Dendreon Corporation Compositions and methods for the treatment of disease associated with Trp-p8 expression
JP4786544B2 (ja) * 2003-11-21 2011-10-05 ジボダン エス エー N置換p−メンタンカルボキサミド類
US20050187211A1 (en) * 2004-02-23 2005-08-25 Wei Edward T. N-arylsalkyl-carboxamide compositions and methods
GB0425661D0 (en) 2004-11-23 2004-12-22 Givaudan Sa Organic compounds
JP2008521942A (ja) 2004-11-29 2008-06-26 ジボダン エス エー 基材ケア製品
GB0504194D0 (en) * 2005-03-02 2005-04-06 Givaudan Sa Organic compounds
BRPI0609447A2 (pt) * 2005-03-24 2010-04-06 Givaudan Sa compostos refrescantes

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106860034A (zh) * 2011-02-23 2017-06-20 奇华顿股份有限公司 有机化合物
CN106860034B (zh) * 2011-02-23 2020-05-19 奇华顿股份有限公司 有机化合物

Also Published As

Publication number Publication date
US11059783B2 (en) 2021-07-13
JP5383191B2 (ja) 2014-01-08
US10221136B2 (en) 2019-03-05
BRPI0616821B1 (pt) 2022-06-07
JP2009507778A (ja) 2009-02-26
EP1917074B1 (en) 2018-02-28
WO2007019719A1 (en) 2007-02-22
US20190194134A1 (en) 2019-06-27
US20100035938A1 (en) 2010-02-11
CN101257949B (zh) 2011-01-19
US20170008845A1 (en) 2017-01-12
EP1917074A1 (en) 2008-05-07
US9452982B2 (en) 2016-09-27
ES2668361T3 (es) 2018-05-17
BRPI0616821A2 (pt) 2012-04-24

Similar Documents

Publication Publication Date Title
CN101257949B (zh) 清凉化合物
USRE44339E1 (en) N-substituted P-menthane carboxamides
EP2167024B1 (en) Cooling compounds
JP5546788B2 (ja) (3S)−3−ヒドロキシブタン酸−l−メンチルの製造方法および冷感剤組成物
US20080176945A1 (en) Carboxilic Acid Amides Provoking A Cooling Sensation
EP1940791B1 (en) Organic compounds
CN101141890A (zh) 清凉化合物
US7935848B2 (en) Butone derivatives useful as cooling agents
US20090098066A1 (en) Substituted bicyclo [2.2.2] oct/5-ene compounds and their use as cooling agents
US20090035364A1 (en) Para-substituted 2-alkoxyphenol compounds
US20240197604A1 (en) Compounds with cooling sensation properties

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant